Amazon Com Inc. bought a new position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 277,777 shares of the company's stock, valued at approximately $134,172,000. Astera Labs comprises about 3.0% of Amazon Com Inc.'s investment portfolio, making the stock its 4th largest holding. Amazon Com Inc. owned about 0.16% of Astera Labs at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently made changes to their positions in ALAB. Reflection Asset Management bought a new position in shares of Astera Labs during the 4th quarter valued at $25,000. Trifecta Capital Advisors LLC bought a new stake in Astera Labs in the second quarter worth $79,000. CX Institutional boosted its holdings in Astera Labs by 1,330.8% in the second quarter. CX Institutional now owns 186 shares of the company's stock worth $90,000 after purchasing an additional 173 shares in the last quarter. Smartleaf Asset Management LLC boosted its holdings in Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company's stock worth $32,000 after purchasing an additional 152 shares in the last quarter. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new position in Astera Labs during the fourth quarter worth $33,000. 60.47% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
ALAB has been the topic of several recent research reports. Zacks Research upgraded Astera Labs from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 11th. JPMorgan Chase & Co. increased their price objective on Astera Labs from $205.00 to $280.00 and gave the company an "overweight" rating in a report on Wednesday, May 6th. Stifel Nicolaus raised their price objective on Astera Labs from $260.00 to $460.00 and gave the company a "buy" rating in a research note on Wednesday, June 24th. UBS Group restated a "neutral" rating and issued a $425.00 target price on shares of Astera Labs in a report on Wednesday, August 5th. Finally, Evercore restated an "outperform" rating and issued a $297.00 target price on shares of Astera Labs in a report on Tuesday, May 19th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and nine have given a Hold rating to the company's stock. According to data from MarketBeat, Astera Labs currently has an average rating of "Moderate Buy" and a consensus target price of $325.25.
Check Out Our Latest Analysis on ALAB
Astera Labs Stock Performance
NASDAQ ALAB opened at $321.61 on Monday. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48. The stock has a market capitalization of $55.80 billion, a PE ratio of 159.21 and a beta of 3.84. The stock has a 50-day simple moving average of $358.00 and a 200 day simple moving average of $240.74.
Astera Labs (NASDAQ:ALAB - Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. During the same quarter last year, the firm posted $0.44 EPS. The company's revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities research analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.
Insider Buying and Selling at Astera Labs
In other Astera Labs news, CEO Jitendra Mohan sold 28,737 shares of the stock in a transaction on Tuesday, May 19th. The shares were sold at an average price of $249.62, for a total value of $7,173,329.94. Following the completion of the sale, the chief executive officer directly owned 3,789,232 shares of the company's stock, valued at $945,868,091.84. This represents a 0.75% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the firm's stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the sale, the chief operating officer owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This represents a 7.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 940,716 shares of company stock valued at $292,425,777 in the last three months. 10.40% of the stock is owned by insiders.
Astera Labs Company Profile
(
Free Report)
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Stories
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.